We are live on ! Find out more
HCM

Hayman Capital Management Portfolio holdings

AUM $63.3M
1-Year Est. Return 3.78%
This Fund
S&P 500
This Quarter Est. Return
-10.66%
1 Year Est. Return
-3.78%
3 Year Est. Return
-44.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$80.2M
AUM Growth
-$137M
Cap. Flow
-$133M
Cap. Flow %
-165.65%
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
–
Reduced
1
Closed
11

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IPXL
Impax Laboratories, Inc.
IPXL
+$21.4M
2
CF icon
CF Industries
CF
+$20.8M
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$19.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.6M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 62.26%
2 Energy 8.32%
3 Healthcare 0%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMIH icon
1
NMI Holdings
NMIH
$3.38B
$49.9M 62.26%
7,371,500
– –
YPF icon
2
CALL
YPF
YPF
$19.1B
$23.6M 29.42%
1,500,000
-750,000
-33% -$13.7M
ESES
3
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
$6.67M 8.32%
2,130,000
– –
ARCT icon
4
Arcturus Therapeutics
ARCT
$178M
– –
-89,399
Closed -$3.78M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-129,501
Closed -$13.6M
CF icon
6
CF Industries
CF
$17.9B
– –
-464,101
Closed -$20.8M
DBVT
7
DBV Technologies
DBVT
$843M
– –
-26,538
Closed -$9.45M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$123B
– –
-100,000
Closed -$10.4M
VTRS icon
9
Viatris
VTRS
$20.6B
– –
-78,905
Closed -$3.18M
ENDP
10
DELISTED
Endo International plc
ENDP
– –
-52,634
Closed -$3.65M
SRRA
11
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-10,555
Closed -$8.66M
GWPH
12
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-210,715
Closed -$19.3M
AGN
13
DELISTED
Allergan plc
AGN
– –
-17,813
Closed -$4.84M
IPXL
14
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-606,618
Closed -$21.4M

Similar funds

LVP
Limestone Value Partners Houston, Texas $64M AUM 4.56% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
HWM
Heartwood Wealth Management London, United Kingdom $58.9M AUM 14.96% 1-Year Est. Return
CCG
Crescent Capital Group Los Angeles, California $56.8M AUM 11.67% 1-Year Est. Return
CSM
Central Square Management Naperville, Illinois $56.6M AUM 27.75% 1-Year Est. Return
KCP
Keane Capital Partners Charlotte, North Carolina $56M AUM
EL
Elberon LLC Austin, Texas $56M AUM 14.07% 1-Year Est. Return

Hayman Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Hayman Capital Management held 14 positions worth $80.2M, down 63% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hayman Capital Management withdrew a net $133M in Q4 2015, closing 11 positions and reducing 1 holding. Its most notable exit was Impax Laboratories, Inc., an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 62% of assets, up from 26% a quarter earlier, followed by Energy and Healthcare.

  • Hayman Capital Management fully exited Impax Laboratories, Inc. in Q4 2015, selling an estimated $21.4M.
  • Hayman Capital Management's ten largest holdings make up 100% of its $80.2M portfolio in Q4 2015.
  • Hayman Capital Management opened 0 new positions and closed 11 in Q4 2015.
  • Hayman Capital Management's portfolio value fell 63% quarter-over-quarter to $80.2M.

Based on Hayman Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.